2Hurria A, Kris MG. Management of lung cancer in older adults. CA Cancer J Clin,2003,53(6) : 325-341.
3Wasil T, Lichtman SM. Clinical pharmacology issues relevant to the dosing and toxicity of chemotherapy drugs in the elderly. Oncologist,2005,10(8) : 602-612.
3Jensen OM, Esteve J, Moller H, et al. Cancer in the European Community and its member states. Eur J Cancer, 1990, 26(11-12): 1167-1256. Erratum in: Eur J Cancer, 1991,27 (12):1717.
4European Network of Cancer Registries (ENCR). (2001) EURO CIM version 4. 0. European Incidence Database V2. 3. Lyon:IARC Press,2001.
5Bray F, Sankila R, Ferlay J, et al. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer,2002,38(1): 99-166.
6Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev, 2005,14(1): 243-250.
7International Agency for Research on Cancer. IARC monographs on the Tobacco Smoke and Involuntary Smoking (Vol. 83). Lyon:IARC Press,2004.
8Liu BQ, Peto R, Chen ZM, et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ,1998,317(7170) : 1411-1422.
9Clinical Trial Service Unit, Oxford University. Emerging Tobacco Hazards in China. http:∥rum. ctsu. ox. ac. uk/tobacco.
10Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, Version 2. 0. IARC CancerBase No. 5. Lyon: IARC Press,2004.
